These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 22682112)
1. Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET. Notni J; Pohle K; Wester HJ EJNMMI Res; 2012 Jun; 2(1):28. PubMed ID: 22682112 [TBL] [Abstract][Full Text] [Related]
2. Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium. Šimeček J; Schulz M; Notni J; Plutnar J; Kubíček V; Havlíčková J; Hermann P Inorg Chem; 2012 Jan; 51(1):577-90. PubMed ID: 22221285 [TBL] [Abstract][Full Text] [Related]
3. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer. Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015 [TBL] [Abstract][Full Text] [Related]
5. Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi Suthiram J; Ebenhan T; Marjanovic-Painter B; Sathekge MM; Zeevaart JR Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575402 [TBL] [Abstract][Full Text] [Related]
6. The influence of the combination of carboxylate and phosphinate pendant arms in 1,4,7-triazacyclononane-based chelators on their 68Ga labelling properties. Máté G; Šimeček J; Pniok M; Kertész I; Notni J; Wester HJ; Galuska L; Hermann P Molecules; 2015 Jul; 20(7):13112-26. PubMed ID: 26197305 [TBL] [Abstract][Full Text] [Related]
7. Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators. Chakravarty R; Chakraborty S; Dash A; Pillai MR Nucl Med Biol; 2013 Feb; 40(2):197-205. PubMed ID: 23218795 [TBL] [Abstract][Full Text] [Related]
8. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26. Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649 [TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging. Ebenhan T; Zeevaart JR; Venter JD; Govender T; Kruger GH; Jarvis NV; Sathekge MM J Nucl Med; 2014 Feb; 55(2):308-14. PubMed ID: 24434293 [TBL] [Abstract][Full Text] [Related]
10. How is (68)Ga labeling of macrocyclic chelators influenced by metal ion contaminants in (68)Ge/(68)Ga generator eluates? Šimeček J; Hermann P; Wester HJ; Notni J ChemMedChem; 2013 Jan; 8(1):95-103. PubMed ID: 23136062 [TBL] [Abstract][Full Text] [Related]
11. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers. Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391 [TBL] [Abstract][Full Text] [Related]
12. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of Xia Y; Zeng C; Zhao Y; Zhang X; Li Z; Chen Y EJNMMI Res; 2020 Apr; 10(1):36. PubMed ID: 32297029 [TBL] [Abstract][Full Text] [Related]
14. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging. Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125 [TBL] [Abstract][Full Text] [Related]
15. Scale down and optimized automated production of [68Ga]68Ga-DOTA-ECL1i PET tracer targeting CCR2 expression. Migliari S; Scarlattei M; Baldari G; Ruffini L EJNMMI Radiopharm Chem; 2023 Feb; 8(1):3. PubMed ID: 36729317 [TBL] [Abstract][Full Text] [Related]